We are live on
!
Find out more
VA
Vident Advisory Portfolio holdings
AUM
$11.7B
1-Year Est. Return
37.32%
This Fund
S&P 500
This Quarter
Est. Return
-2.08%
1 Year Est. Return
+37.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.84B
AUM Growth
+$1.14B
(+20%)
Cap. Flow
+$1.49B
Cap. Flow
% of AUM
21.78%
Top 10 Holdings %
Top 10 Hldgs %
18.99%
Holding
1,657
New
217
Increased
942
Reduced
370
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$52.4M |
| 2 |
NVIDIA
NVDA
|
+$47.2M |
| 3 |
Microsoft
MSFT
|
+$45M |
| 4 |
Fortinet
FTNT
|
+$44M |
| 5 |
General Dynamics
GD
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$28.3M |
| 2 |
Chevron
CVX
|
+$26.4M |
| 3 |
Coca-Cola
KO
|
+$25.5M |
| 4 |
ExxonMobil
XOM
|
+$16.9M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$13.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.16% |
| 2 | Financials | 13.02% |
| 3 | Industrials | 11.79% |
| 4 | Consumer Discretionary | 8.06% |
| 5 | Communication Services | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Genmab
GMAB
$17.7B
| $242K | ﹤0.01% |
+12,377
| New | +$260K |
|
1352
Mercury Insurance
MCY
$5.94B
| $242K | ﹤0.01% |
4,332
+60
| +1% | +$3.23K |
|
1353
Advanced Energy
AEIS
$12.2B
| $242K | ﹤0.01% |
+2,537
| New | +$290K |
|
1354
JFrog
FROG
$9.71B
| $242K | ﹤0.01% |
+7,554
| New | +$263K |
|
|
AUTL
1355
Autolus Therapeutics
AUTL
$386M
| $241K | ﹤0.01% |
+155,504
| New | +$316K |
|
1356
Ollie's Bargain Outlet
OLLI
$4.01B
| $241K | ﹤0.01% |
+2,069
| New | +$219K |
|
1357
QuidelOrtho
QDEL
$1.09B
| $240K | ﹤0.01% |
+6,865
| New | +$280K |
|
1358
ARK Innovation ETF
ARKK
$5.69B
| $240K | ﹤0.01% |
5,034
-1,512
| -23% | -$86.6K |
|
1359
Magnite
MGNI
$2.65B
| $239K | ﹤0.01% |
20,989
+487
| +2% | +$7.76K |
|
1360
Applied Industrial Technologies
AIT
$12.8B
| $239K | ﹤0.01% |
+1,062
| New | +$262K |
|
1361
Sarepta Therapeutics
SRPT
$1.66B
| $239K | ﹤0.01% |
3,748
+815
| +28% | +$85.8K |
|
1362
J.M. Smucker
SJM
$12.6B
| $239K | ﹤0.01% |
+2,019
| New | +$218K |
|
1363
Westrock Coffee
WEST
$741M
| $239K | ﹤0.01% |
33,052
-7,406
| -18% | -$48.5K |
|
1364
Archrock
AROC
$6.33B
| $237K | ﹤0.01% |
9,032
+420
| +5% | +$11.3K |
|
1365
Golub Capital BDC
GBDC
$3.33B
| $237K | ﹤0.01% |
+15,634
| New | +$240K |
|
1366
FMC
FMC
$1.42B
| $237K | ﹤0.01% |
+5,610
| New | +$249K |
|
1367
Lithia Motors
LAD
$7.78B
| $236K | ﹤0.01% |
805
+25
| +3% | +$8.51K |
|
1368
Olin
OLN
$2.64B
| $236K | ﹤0.01% |
+9,740
| New | +$274K |
|
1369
iShares MBS ETF
MBB
$39B
| $235K | ﹤0.01% |
2,508
| – | – |
|
1370
WPP
WPP
$4.04B
| $235K | ﹤0.01% |
6,194
+459
| +8% | +$20.4K |
|
1371
Old National Bancorp
ONB
$10.1B
| $234K | ﹤0.01% |
+11,024
| New | +$248K |
|
1372
Hawaiian Electric Industries
HE
$2.33B
| $233K | ﹤0.01% |
+21,311
| New | +$215K |
|
1373
Agilysys
AGYS
$2.78B
| $233K | ﹤0.01% |
3,207
+630
| +24% | +$57.6K |
|
1374
Sabra Healthcare REIT
SBRA
$5.64B
| $232K | ﹤0.01% |
13,302
-7,583
| -36% | -$128K |
|
1375
Aurinia Pharmaceuticals
AUPH
$1.97B
| $232K | ﹤0.01% |
+28,831
| New | +$234K |
|
Similar funds
HTC
BCI
VIA
NYLIM
PI
UE
LC
MG
Vident Advisory's Q1 2025 Portfolio in Review
As of Q1 2025, Vident Advisory held 1,657 positions worth $6.84B, up 20% from $5.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Vident Advisory deployed $1.49B of net new capital in Q1 2025, opening 217 new positions and adding to 942 existing holdings. Its largest new stake was CVB Financial: 194,707 shares worth $3.59M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $28.3M trimmed.
- Vident Advisory's largest Q1 2025 buy was CVB Financial: 194,707 shares worth $3.59M.
- Vident Advisory added most to Palo Alto Networks in Q1 2025, an estimated $52.4M increase.
- Vident Advisory's biggest Q1 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $28.3M.
- Vident Advisory fully exited Timothy Plan US Large/Mid Cap Core ETF in Q1 2025, selling an estimated $6.54M.
- Vident Advisory's ten largest holdings make up 19% of its $6.84B portfolio in Q1 2025.
- Vident Advisory opened 217 new positions and closed 105 in Q1 2025.
- Vident Advisory's portfolio value rose 20% quarter-over-quarter to $6.84B.
Based on Vident Advisory's 13F filing for Q1 2025, filed 15 May 2025.